Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngoscopy | 5 | 2022 | 711 | 1.520 |
Why?
|
| Microsurgery | 4 | 2021 | 796 | 1.480 |
Why?
|
| Free Tissue Flaps | 3 | 2024 | 328 | 1.410 |
Why?
|
| Monitoring, Intraoperative | 3 | 2021 | 957 | 1.300 |
Why?
|
| Oropharyngeal Neoplasms | 6 | 2023 | 477 | 1.180 |
Why?
|
| Laryngectomy | 6 | 2023 | 248 | 1.090 |
Why?
|
| Larynx | 3 | 2022 | 494 | 0.770 |
Why?
|
| Head and Neck Neoplasms | 7 | 2023 | 2734 | 0.750 |
Why?
|
| Larynx, Artificial | 1 | 2020 | 69 | 0.740 |
Why?
|
| Laryngoplasty | 1 | 2020 | 53 | 0.740 |
Why?
|
| Carcinoma, Squamous Cell | 8 | 2023 | 4034 | 0.720 |
Why?
|
| Neck | 3 | 2021 | 697 | 0.630 |
Why?
|
| Rhinitis | 4 | 2017 | 691 | 0.630 |
Why?
|
| Laryngeal Diseases | 1 | 2021 | 241 | 0.610 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2017 | 41 | 0.580 |
Why?
|
| Narcotics | 1 | 2019 | 343 | 0.570 |
Why?
|
| Sinusitis | 4 | 2017 | 923 | 0.560 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2016 | 54 | 0.540 |
Why?
|
| Mouth Mucosa | 1 | 2018 | 434 | 0.530 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2018 | 298 | 0.500 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 604 | 0.490 |
Why?
|
| Otologic Surgical Procedures | 1 | 2016 | 145 | 0.490 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 379 | 0.490 |
Why?
|
| Postoperative Complications | 9 | 2024 | 15295 | 0.480 |
Why?
|
| Thyroidectomy | 1 | 2019 | 879 | 0.460 |
Why?
|
| Otolaryngology | 2 | 2019 | 645 | 0.460 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 987 | 0.460 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2017 | 1121 | 0.460 |
Why?
|
| Benchmarking | 1 | 2019 | 1042 | 0.440 |
Why?
|
| Paranasal Sinuses | 3 | 2020 | 250 | 0.430 |
Why?
|
| Pain, Postoperative | 2 | 2020 | 1643 | 0.420 |
Why?
|
| Neuroma, Acoustic | 1 | 2016 | 451 | 0.410 |
Why?
|
| Pressure | 3 | 2021 | 1203 | 0.400 |
Why?
|
| Temporal Bone | 1 | 2016 | 661 | 0.400 |
Why?
|
| Excipients | 1 | 2011 | 96 | 0.380 |
Why?
|
| Leucine | 1 | 2011 | 561 | 0.340 |
Why?
|
| Tongue Neoplasms | 2 | 2023 | 180 | 0.320 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 1475 | 0.320 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2017 | 1008 | 0.320 |
Why?
|
| Stress, Mechanical | 3 | 2019 | 1686 | 0.310 |
Why?
|
| Arteries | 2 | 2022 | 1119 | 0.290 |
Why?
|
| Neoplasm Staging | 4 | 2023 | 11031 | 0.290 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 1587 | 0.280 |
Why?
|
| Equipment Design | 3 | 2021 | 3582 | 0.280 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2017 | 84 | 0.270 |
Why?
|
| Deglutition Disorders | 2 | 2023 | 605 | 0.240 |
Why?
|
| Dilatation | 3 | 2023 | 291 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3336 | 0.210 |
Why?
|
| Esophageal Stenosis | 1 | 2023 | 195 | 0.210 |
Why?
|
| Indocyanine Green | 1 | 2023 | 239 | 0.200 |
Why?
|
| Neck Dissection | 2 | 2023 | 197 | 0.200 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6364 | 0.190 |
Why?
|
| Glossectomy | 2 | 2023 | 58 | 0.190 |
Why?
|
| Forearm | 1 | 2023 | 409 | 0.190 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15540 | 0.190 |
Why?
|
| Humans | 47 | 2024 | 744343 | 0.190 |
Why?
|
| Scapula | 1 | 2021 | 164 | 0.180 |
Why?
|
| Cautery | 1 | 2020 | 72 | 0.180 |
Why?
|
| Nose Deformities, Acquired | 1 | 2020 | 44 | 0.180 |
Why?
|
| Radius | 1 | 2023 | 422 | 0.180 |
Why?
|
| Prospective Studies | 8 | 2022 | 53288 | 0.180 |
Why?
|
| Ranula | 1 | 2019 | 11 | 0.170 |
Why?
|
| Speech | 2 | 2023 | 540 | 0.170 |
Why?
|
| Lingual Nerve | 1 | 2019 | 33 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 2219 | 0.170 |
Why?
|
| Phonation | 1 | 2020 | 219 | 0.170 |
Why?
|
| Suction | 1 | 2020 | 267 | 0.170 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 155 | 0.170 |
Why?
|
| Models, Biological | 1 | 2015 | 9583 | 0.170 |
Why?
|
| Capital Financing | 1 | 2019 | 58 | 0.170 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3589 | 0.160 |
Why?
|
| Mouth | 1 | 2021 | 374 | 0.160 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2017 | 1855 | 0.160 |
Why?
|
| Nasal Obstruction | 1 | 2020 | 151 | 0.160 |
Why?
|
| Retrospective Studies | 18 | 2024 | 77449 | 0.160 |
Why?
|
| Nasopharynx | 1 | 2020 | 379 | 0.150 |
Why?
|
| Comprehension | 1 | 2023 | 610 | 0.150 |
Why?
|
| Investments | 1 | 2019 | 143 | 0.150 |
Why?
|
| Muscimol | 1 | 2017 | 69 | 0.150 |
Why?
|
| Endoscopy | 4 | 2020 | 1785 | 0.150 |
Why?
|
| Oral Surgical Procedures | 1 | 2019 | 168 | 0.150 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2019 | 252 | 0.140 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2016 | 49 | 0.140 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 281 | 0.140 |
Why?
|
| Middle Aged | 18 | 2024 | 213383 | 0.140 |
Why?
|
| Laryngoscopes | 1 | 2018 | 148 | 0.140 |
Why?
|
| Tympanoplasty | 1 | 2016 | 71 | 0.140 |
Why?
|
| Pharyngectomy | 1 | 2015 | 45 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 1081 | 0.140 |
Why?
|
| Head | 1 | 2021 | 880 | 0.140 |
Why?
|
| Male | 23 | 2024 | 350118 | 0.130 |
Why?
|
| Device Removal | 1 | 2020 | 656 | 0.130 |
Why?
|
| Chickens | 1 | 2017 | 865 | 0.130 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 1206 | 0.130 |
Why?
|
| Hot Temperature | 1 | 2021 | 1354 | 0.130 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 977 | 0.130 |
Why?
|
| Glucagon | 1 | 2017 | 533 | 0.130 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2014 | 62 | 0.120 |
Why?
|
| Trachea | 1 | 2020 | 1076 | 0.120 |
Why?
|
| Esophagus | 1 | 2020 | 1019 | 0.120 |
Why?
|
| Morphine | 1 | 2019 | 657 | 0.120 |
Why?
|
| Speech Disorders | 1 | 2015 | 189 | 0.120 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2015 | 129 | 0.120 |
Why?
|
| Prosthesis Design | 1 | 2020 | 2110 | 0.120 |
Why?
|
| Aged | 13 | 2021 | 163280 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15076 | 0.120 |
Why?
|
| Efficiency | 1 | 2017 | 462 | 0.120 |
Why?
|
| Palatine Tonsil | 1 | 2014 | 193 | 0.120 |
Why?
|
| Internationality | 1 | 2019 | 1003 | 0.120 |
Why?
|
| Finite Element Analysis | 1 | 2015 | 431 | 0.110 |
Why?
|
| Surgical Flaps | 2 | 2019 | 1640 | 0.110 |
Why?
|
| Conflict of Interest | 1 | 2018 | 544 | 0.110 |
Why?
|
| Niacinamide | 1 | 2015 | 417 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 1387 | 0.110 |
Why?
|
| Vestibular Diseases | 1 | 2015 | 217 | 0.110 |
Why?
|
| Adult | 14 | 2022 | 214055 | 0.100 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 528 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 2015 | 512 | 0.100 |
Why?
|
| Surgery, Oral | 1 | 2014 | 146 | 0.100 |
Why?
|
| Blood Glucose | 2 | 2017 | 6256 | 0.100 |
Why?
|
| Parotid Gland | 2 | 2023 | 168 | 0.100 |
Why?
|
| Trehalose | 1 | 2011 | 88 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 1116 | 0.090 |
Why?
|
| Female | 19 | 2024 | 380194 | 0.090 |
Why?
|
| Chronic Disease | 4 | 2017 | 9146 | 0.090 |
Why?
|
| Receptors, GABA-A | 1 | 2014 | 627 | 0.090 |
Why?
|
| Crystallization | 1 | 2011 | 524 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2017 | 5078 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 35421 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 964 | 0.080 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2011 | 247 | 0.080 |
Why?
|
| Aerosols | 1 | 2011 | 625 | 0.080 |
Why?
|
| Microspheres | 1 | 2011 | 777 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2021 | 9849 | 0.080 |
Why?
|
| Ethanol | 1 | 2014 | 1342 | 0.080 |
Why?
|
| Logistic Models | 2 | 2021 | 13408 | 0.080 |
Why?
|
| Calcium | 1 | 2021 | 5756 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2014 | 891 | 0.070 |
Why?
|
| Robotics | 1 | 2014 | 899 | 0.070 |
Why?
|
| Biopsy | 1 | 2018 | 6756 | 0.070 |
Why?
|
| Tongue | 2 | 2023 | 406 | 0.070 |
Why?
|
| Software | 1 | 2021 | 4443 | 0.070 |
Why?
|
| Cicatrix | 2 | 2023 | 764 | 0.070 |
Why?
|
| Tracheostomy | 2 | 2023 | 401 | 0.070 |
Why?
|
| Quality of Life | 4 | 2023 | 12804 | 0.070 |
Why?
|
| Cadaver | 2 | 2020 | 1337 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2023 | 63114 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 15226 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3674 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7880 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 19905 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5686 | 0.060 |
Why?
|
| Lymphatic Metastasis | 2 | 2022 | 2924 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2214 | 0.050 |
Why?
|
| Pain | 1 | 2017 | 4986 | 0.050 |
Why?
|
| Physicians | 1 | 2020 | 4567 | 0.050 |
Why?
|
| Medicare | 1 | 2020 | 6566 | 0.050 |
Why?
|
| Sensation | 1 | 2023 | 336 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
| Fibula | 1 | 2024 | 269 | 0.050 |
Why?
|
| Weight-Bearing | 1 | 2024 | 515 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2014 | 3313 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2014 | 1813 | 0.050 |
Why?
|
| Leucine Zippers | 1 | 2021 | 117 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10481 | 0.050 |
Why?
|
| Fluorescence | 1 | 2023 | 751 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12959 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 1107 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 407 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2017 | 3913 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4253 | 0.040 |
Why?
|
| Palate, Soft | 1 | 2019 | 96 | 0.040 |
Why?
|
| Nasal Septum | 1 | 2020 | 127 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 7181 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 57776 | 0.040 |
Why?
|
| Dissection | 1 | 2019 | 295 | 0.040 |
Why?
|
| Nasal Cavity | 1 | 2019 | 313 | 0.040 |
Why?
|
| Depression | 1 | 2017 | 7766 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 549 | 0.040 |
Why?
|
| Perception | 1 | 2023 | 1198 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2023 | 21746 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2019 | 25043 | 0.040 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2016 | 41 | 0.040 |
Why?
|
| Animals | 3 | 2017 | 168757 | 0.030 |
Why?
|
| Time Factors | 3 | 2014 | 40075 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2021 | 2557 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 20129 | 0.030 |
Why?
|
| Nose | 1 | 2019 | 509 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 1917 | 0.030 |
Why?
|
| SEER Program | 1 | 2020 | 1508 | 0.030 |
Why?
|
| Maryland | 1 | 2015 | 276 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 1770 | 0.030 |
Why?
|
| Speech Intelligibility | 1 | 2015 | 81 | 0.030 |
Why?
|
| Saccule and Utricle | 1 | 2015 | 81 | 0.030 |
Why?
|
| Vestibular Function Tests | 1 | 2015 | 127 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 21683 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2015 | 215 | 0.030 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2015 | 88 | 0.030 |
Why?
|
| Cleft Palate | 1 | 2019 | 560 | 0.030 |
Why?
|
| Semicircular Canals | 1 | 2015 | 198 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2015 | 309 | 0.030 |
Why?
|
| Survival Rate | 2 | 2019 | 12788 | 0.030 |
Why?
|
| Mice | 2 | 2017 | 81183 | 0.030 |
Why?
|
| Lung | 1 | 2011 | 9856 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 3479 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13695 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 1011 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2024 | 40561 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23403 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2014 | 1137 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 11725 | 0.020 |
Why?
|
| Internet | 1 | 2023 | 3064 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8324 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2015 | 921 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2020 | 2530 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2015 | 1275 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2014 | 1486 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 1540 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 4201 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6489 | 0.020 |
Why?
|
| Linear Models | 1 | 2014 | 5952 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8642 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
| Contrast Media | 1 | 2015 | 5300 | 0.010 |
Why?
|
| United States | 2 | 2020 | 69872 | 0.010 |
Why?
|
| Length of Stay | 1 | 2014 | 6309 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12245 | 0.010 |
Why?
|
| Cell Line | 1 | 2014 | 15997 | 0.010 |
Why?
|
| Insulin | 1 | 2014 | 6580 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16365 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4468 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 72290 | 0.010 |
Why?
|
| Rats | 1 | 2014 | 24260 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 23338 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39050 | 0.010 |
Why?
|
Concepts
(237)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_